Proton pump inhibitors (antacids): possible risk of Clostridium difficile-associated diarrhea
February 16, 2012
Health Canada, Advisories and Warnings
OTTAWA - Health Canada is informing Canadians of a possible association between the use of prescription stomach antacids known as proton pump inhibitors (PPIs) and an increased risk of Clostridium difficile-associated diarrhea (CDAD).
Click here to read the advisory from Health Canada.
